I agree that this site is using cookies. You can find further informations here.
X
Thaci, Diamant
154  results:
OpenAccess-fulltext X
Search for persons X
?
1

Hair Loss Profiles and Ritlecitinib Efficacy in Patients wi..:

Thaçi, Diamant ; Tziotzios, Christos ; Ito, Taisuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613177/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Efficacy and Safety of Abrocitinib in Patients with Severe ..:

Simpson, Eric L ; Silverberg, Jonathan I ; Thyssen, Jacob P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293387/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

A life for autoimmune blistering diseases: in memoriam Detl..:

Hundt, Jennifer E ; Sadik, Christian D ; Beek, Nina van...
https://freidok.uni-freiburg.de/data/241157.  , 2023
Link: https://freidok.uni-frei..
 
?
4

Cutaneous lupus erythematosus is associated with an increas..:

Olbrich, Henning ; Kridin, Khalaf ; Zirpel, Henner...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279782/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

No impact of disease duration on response to tildrakizumab ..:

Griss, Johannes ; Ratzinger, Gudrun ; Maul, Julia‐Tatjana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549803/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Bimekizumab in patients with active psoriatic arthritis and..:

Merola, Joseph, F ; Landewé, Robert ; Mcinnes, Iain, B...
info:eu-repo/semantics/altIdentifier/doi/10.1016/S0140-6736(22)02303-0.  , 2023
Link: https://hal.science/hal-..
 
?
7

Dupilumab Safety and Efficacy in a Phase III Open-Label Ext..:

Cork, Michael ; Thaçi, Diamant ; Arkwright, Peter...
qt1rw3692c.  , 2023
Link: https://escholarship.org..
 
?
8

Bimekizumab in patients with active psoriatic arthritis and..:

Merola, Joseph F ; Landewé, Robert ; McInnes, Iain B...
https://eprints.gla.ac.uk/286276/1/286276.pdf.  , 2023
Link: https://eprints.gla.ac.u..
 
?
9

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus O..:

Papp, Kim A ; Lebwohl, Mark G ; Thaçi, Diamant...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10789833/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Dupilumab Demonstrates Rapid Onset of Action in Improving S..:

Augustin, Matthias ; Bauer, Andrea ; Ertner, Konstantin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984619/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Healthcare Professional (HCP) and Patient Usability Evaluat..:

Corominas, Héctor ; Young, David ; Cummings, J. R. Fraser...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480234/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Price variability of TNF-α inhibitor biosimilars among Euro..:

Geat, Davide ; Gisondi, Paolo ; Maurelli, Martina...
info:eu-repo/semantics/altIdentifier/pmid/38108512.  , 2023
Link: https://hdl.handle.net/1..
 
?
13

Lichen sclerosus: The 2023 update:

De Luca, David A ; Papara, Cristian ; Vorobyev, Artem...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978401/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

A concept for integrated care pathways for atopic dermatiti..:

Zuberbier, Torsten ; Abdul Latiff, Amir ; Aggelidis, Xenofon...
https://pure.au.dk/portal/en/publications/60f354c7-9deb-446e-868d-d89a1a29035f.  , 2023
Link: https://pure.au.dk/porta..
 
?
15

Dupilumab Safety and Efficacy in a Phase III Open-Label Ext..:

Cork, Michael J ; Thaçi, Diamant ; Eichenfield, Lawrence F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613196/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15